Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Malaria vaccination begins
Wed April 24th - The first ever national malaria vaccine campaign was launched yesterday in the African country of Malawi. More
Hope for repairing foetal membranes
Wed April 24th - New discoveries could enable successful treatment of ruptured foetal membranes, British researchers have reported. More
Gene link to cannabis addiction
Wed April 24th - Genetics plays a role in individual risk of becoming addicted to cannabis, British researchers reported today. More
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...

England split by pain divide

Wednesday September 12th, 2018

England suffers a clear North-South geographical split in rates of chronic pain, according to an analysis published today.

Dr Adam Todd of Newcastle University, UK, and colleagues also found a North-South divide in use of potentially addictive opioid drugs.

The team say that: "Chronic pain is a worldwide problem, and the burden it places on our society is increasing." They add that, to manage chronic pain, some treatment strategies rely on the use of opioid analgesics, "although there are very few studies to support their long-term effectiveness".

The study found regional inequalities in rates of chronic pain prevalence, pain intensity and opioid, from figures on 5,711 people in the Health Survey for England 2011.

'The North' covered The North East, North West, and Yorkshire and the Humber regions. 'The South' covered London, East of England, West Midlands, East Midlands, South East, and South West regions.

Rates of chronic pain were higher in the North than the South - 37 per cent versus 35 per cent. Opioid use was also higher in the North: 2.5 per cent versus 1.7 per cent.

In today's (12 September) BMJ Open they write: "People in the North of England more likely to have 'severely limiting' or 'moderately limiting' chronic pain." Furthermore, "The intensity of chronic pain was significantly and positively associated with the use of opioid analgesics."

The experts state that more guidance is needed to support prescribers in the management of chronic pain. "To develop future strategies going forward, and avoid a potential 'opioid epidemic', as observed in the USA, it is important that consideration is given to other ways of managing chronic pain," they conclude.

Todd, A. et al. The Pain Divide: a cross-sectional analysis of chronic pain prevalence, pain intensity and opioid utilisation in England. BMJ Open 12 September 2018; doi: 10.1136/bmjopen-2018-023391

Tags: Pain Relief | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)